查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1908507

美国器官捐赠和移植软体市场规模、份额和趋势分析报告：按软体类型、部署类型、应用、最终用途和细分市场预测（2026-2033 年）

U.S. Organ Donation And Transplant Software Market Size, Share & Trends Analysis Report By Software Type, By Deployment Mode (Cloud-based, On-premise), By Application (Organ Donation Workflow Automation), By End-use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

美国器官捐赠与移植软体市场概览

2025年美国器官捐赠和移植软体市场规模估计为5,716万美元，预计2033年将达到9,004万美元。

预计从 2026 年到 2033 年，该行业将以 5.9% 的复合年增长率成长。这一增长是由器官移植数量和需求的增加、终末期器官疾病患病率的上升、标准化数据报告和註册提交的监管要求以及快速准确地进行供体-受体匹配的需求所驱动的。

美国器官移植数量的不断增长显着加速了器官捐赠和移植软体的普及应用。根据美国器官捐赠者联合网络（UNOS）统计，2024年美国器官移植手术数量超过48,000例，较2015年增长55%，凸显了美国器官移植事业规模的不断扩大和復杂性的日益增加。这种成长给器官捐赠组织（OPO）和移植中心带来了巨大压力，包括管理大规模的捐赠者库、更频繁地进行配型、加快决策週期以及管理日益复杂的后勤工作流程。因此，亟需先进的软体解决方案来简化捐赠者管理、实现分配和配型自动化、提高资料准确性、确保合规性并支援整个移植生态系统的即时协作。

在美国，标准化数据报告和提交至註册机构的监管要求是器官捐赠和移植软体市场的主要驱动力。移植中心、器官获取组织 (OPO) 和组织配型检查室必须向国家机构（如 OPTN/UNOS 和 HRSA）提交全面及时的临床、运营和结果数据，包括捐赠者特征、匹配实践、器官捐赠、移植事件和长期移植后随访。

这些强制性报告要求，以及严格的审核追踪、品质指标和合规标准，催生了对能够自动收集数据、确保准确性、与电子健康记录 (EHR) 和实验室系统保持互通性并简化註册提交流程的软体平台的需求。日益严格的监管审查和对数据透明度的更高期望，正促使各机构采用先进的数位化解决方案，以减轻行政负担、避免合规漏洞，并确保在整个移植过程中报告的一致性和标准化。

美国医疗保健人工智慧整合器官捐赠和移植软体市场

人工智慧在器官捐赠和移植工作流程的应用，正推动美国先进数位平台的广泛普及。移植中心和器官捐赠组织（OPO）越来越依赖智慧工具来提高供受者配对的准确性、加快决策速度并改善整体移植效果。人工智慧能够实现预测分析、自动风险评分、快速数据处理以及临床和营运团队之间的高效协作。 LifeFuser 是 Ataims Tech 公司推出的安全、基于云端的 AI 驱动型移植管理平台，旨在优化器官移植工作流程，包括供受者配对和即时分析。

肾臟、肝臟、心臟、肺臟和胰臟移植计画透过预测结果模型、客製化工作流程和全面的数据集成，为器官移植的各个阶段提供支持，同时确保符合 HIPAA 和 GDPR 法规。这类平台展现了人工智慧如何重塑移植手术流程，并推动美国器官捐赠和移植软体市场的成长。

目录

第一章调查方法和范围

第二章执行摘要

第三章 市场变数、趋势与范围

  • 市场趋势展望
  • 市场动态
  • 商业环境分析
    • 波特五力分析
    • PESTLE分析

第四章美国器官捐赠和移植软体市场：按软体类型分類的预测和趋势分析

  • 按软体类型分類的市占率变化分析（2025 年和 2033 年）
  • 按软体类型分類的市场规模、预测和趋势分析（2021-2033 年）
  • 器官捐赠管理系统
  • 移植管理系统
  • 器官分配与匹配平台
  • 器官取得及物流软体
  • 其他（註册资料管理系统等）

第五章：美国器官捐赠和移植软体市场——按部署类型划分、估算和趋势分析

  • 按安装类型分類的市场份额变化分析（2025 年和 2033 年）
  • 按实施类型分類的市场规模、预测和趋势分析（2021-2033 年）
  • 基于云端的
  • 本地部署

第六章：美国器官捐赠和移植软体市场按应用、估算和趋势分析

  • 按应用领域分類的市占率变化分析（2025 年和 2033 年）
  • 按应用领域分類的市场规模、预测和趋势分析（2021-2033 年）
  • 器官捐赠工作流程自动化
  • 等候名单和接收者管理
  • 移植协调和日程安排
  • 监理报告合规性
  • 结果数据分析

第七章美国器官捐赠和移植软体市场：按最终用途分類的估算和趋势分析

  • 按最终用途分類的市占率变化分析（2025 年和 2033 年）
  • 按最终用途分類的市场规模、预测和趋势分析（2021-2033 年）
  • 医院及移植中心
  • 器官获取组织（OPO）
  • 国家和地方卫生组织
  • 研究和学术机构

第八章 竞争情势

  • 企业市场分析
  • 公司分类
  • 公司简介/列表
    • InVita Healthcare Technologies
    • XVIVO
    • CareDx
    • Afflo
    • Ataims Tech
    • MedSleuth, Inc.
    • EDITLife
    • Buckeye Transplant Solutions
    • United Network for Organ Sharing
Product Code: GVR-4-68040-838-6

U.S. Organ Donation And Transplant Software Market Summary

The U.S organ donation and transplant software market size was estimated at USD 57.16 million in 2025 and is projected to reach USD 90.04 million by 2033, growing at a CAGR of 5.9% from 2026 to 2033. This growth is attributed to the increasing organ transplant volumes and demand, growing prevalence of end-stage organ diseases, regulatory requirements for standardized data reporting and registry submission, and need for faster, more accurate donor-recipient matching.

Increasing organ transplant volumes in the U.S. are significantly accelerating the adoption of organ donation and transplant software. According to United Network for Organ Sharing, more than 48,000 organ transplants were performed in the U.S. in 2024, with a 55% increase in transplant procedures since 2015, highlighting the expanding scale and complexity of national transplant operations. This rise places substantial pressure on OPOs and transplant centers to manage larger donor pools, higher match-run frequencies, faster decision cycles, and more intricate logistics workflows. As a result, advanced software solutions are increasingly required to streamline donor management, automate allocation and matching, enhance data accuracy, ensure regulatory compliance, and support real-time coordination across the entire transplant ecosystem.

Regulatory requirements for standardized data reporting and registry submission are a major driver of the U.S. organ donation and transplant software market. Transplant centers, OPOs, and histocompatibility labs must submit comprehensive and timely clinical, operational, and outcome data to national bodies such as the OPTN/UNOS and the HRSA, covering donor characteristics, match runs, organ offers, transplant events, and long-term post-transplant follow-up.

These mandatory reporting obligations, along with strict audit trails, quality metrics, and compliance standards, create a need for software platforms that can automate data capture, ensure accuracy, maintain interoperability with EHRs and laboratory systems, and streamline registry submissions. As regulatory scrutiny and data transparency expectations continue to increase, organizations are turning to advanced digital solutions to reduce administrative burden, avoid compliance gaps, and ensure consistent, standardized reporting across the transplant continuum.

Integration of AI in U.S. Healthcare Organ Donation & Transplant Software market

The integration of AI into organ donation and transplant workflows is driving strong adoption of advanced digital platforms in the U.S., as transplant centers and OPOs increasingly rely on intelligent tools to improve donor-recipient matching accuracy, accelerate decision-making, and enhance overall transplant outcomes. AI enables predictive analytics, automated risk scoring, faster data processing, and more efficient coordination across clinical and operational teams. LifeFuser is a secure, cloud-based AI-driven transplant management platform by Ataims Tech designed to optimize organ transplant workflows, including donor-recipient matching and real-time analytics.

It supports all phases of organ transplantation with predictive outcome modeling, customizable workflows, and comprehensive data integration across kidney, liver, heart, lung, and pancreas programs, while ensuring HIPAA and GDPR compliance. Such platforms demonstrate how AI is reshaping transplant operations and contributing to the growth of the U.S. organ donation and transplant software market.

U.S. Healthcare Organ Donation And Transplant Software Market Report Segmentation

This report forecasts revenue growth at regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. healthcare organ donation and transplant software market report based software type, deployment mode, application, and end-use:

  • Software Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Organ Donor Management Systems
  • Transplant Management Systems
  • Organ Allocation & Matching Platforms
  • Organ Procurement & Logistics Software
  • Others
  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Cloud-based
  • On-premise
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Organ Donation Workflow Automation
  • Waitlist & Recipient Management
  • Transplant Coordination & Scheduling
  • Regulatory Reporting & Compliance
  • Outcome & Data Analytics
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Transplant Centers
  • Organ Procurement Organizations (OPOs)
  • National/Regional Health Agencies
  • Research & Academic Institutes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Software Type
    • 1.2.2. Deployment Mode
    • 1.2.3. Application
    • 1.2.4. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing organ transplant volumes and demand
      • 3.2.1.2. Growing prevalence of end-stage organ diseases
      • 3.2.1.3. Regulatory requirements for standardized data reporting and registry submission
      • 3.2.1.4. Need for faster, more accurate donor-recipient matching
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High implementation and maintenance costs of advanced software platforms.
      • 3.2.2.2. Limited IT infrastructure and digital readiness in smaller hospitals or OPOs.
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Technology Overview
    • 3.2.6. Regulatory Overview
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. U.S. Organ Donation and Transplant Software Market: Software Type Estimates & Trend Analysis

  • 4.1. Solution Segment Dashboard
  • 4.2. Solution Market Share Movement Analysis, 2025 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Solution, 2021 to 2033 (USD Million)
  • 4.4. Organ Donor Management Systems
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Transplant Management Systems
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Organ Allocation & Matching Platforms
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Organ Procurement & Logistics Software
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others (Registry & Data Management System, etc.)
    • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Organ Donation and Transplant Software Market: Deployment Mode Estimates & Trend Analysis

  • 5.1. Deployment Mode Segment Dashboard
  • 5.2. Deployment Mode Market Share Movement Analysis, 2025 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 5.4. Cloud-based
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. On-premise
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Organ Donation and Transplant Software Market: Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Application Market Share Movement Analysis, 2025 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Organ Donation Workflow Automation
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Waitlist & Recipient Management
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Transplant Coordination & Scheduling
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Regulatory Reporting & Compliance
    • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Outcome & Data Analytics
    • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Healthcare Organ Donation and Transplant Software Market: End Use Estimates & Trend Analysis

  • 7.1. End use Segment Dashboard
  • 7.2. End use Market Share Movement Analysis, 2025 & 2033
  • 7.3. Market Size & Forecasts and Trend Analysis, by End use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals & Transplant Centers
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Organ Procurement Organizations (OPOs)
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. National/Regional Health Agencies
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Research & Academic Institutes
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Market Position Analysis
  • 8.2. Company Categorization
  • 8.3. Company Profiles/Listing
    • 8.3.1. InVita Healthcare Technologies
      • 8.3.1.1. Participant Overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. XVIVO
      • 8.3.2.1. Participant Overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. CareDx
      • 8.3.3.1. Participant Overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Afflo
      • 8.3.4.1. Participant Overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Ataims Tech
      • 8.3.5.1. Participant Overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. MedSleuth, Inc.
      • 8.3.6.1. Participant Overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. EDITLife
      • 8.3.7.1. Participant Overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Buckeye Transplant Solutions
      • 8.3.8.1. Participant Overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. United Network for Organ Sharing
      • 8.3.9.1. Participant Overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. Healthcare Organ Donation & Transplant Software market, by software type, 2021 - 2033 (USD Million)
  • Table 4. U.S. Healthcare Organ Donation & Transplant Software market, by deployment model, 2021 - 2033 (USD Million)
  • Table 5. U.S. Healthcare Organ Donation & Transplant Software market, by application, 2021 - 2033 (USD Million)
  • Table 6. U.S. Healthcare Organ Donation & Transplant Software market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. Organ Donation & Transplant Software market: Market outlook
  • Fig. 5 U.S. Organ Donation & Transplant Software market: Segment outlook
  • Fig. 6 U.S. Organ Donation & Transplant Software market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. Organ Donation & Transplant Software Market Driver Impact
  • Fig. 9 U.S. Organ Donation & Transplant Software market Restraint impact
  • Fig. 10 U.S. Organ Donation & Transplant Software market, Software Type outlook key takeaways (USD Million)
  • Fig. 11 U.S. Organ Donation & Transplant Software market: Software Type movement analysis (USD Million)
  • Fig. 12 Organ Donor Management Systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Transplant Management Systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Organ Allocation & Matching Platforms market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Organ Procurement & Logistics Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Others (Registry & Data Management System, etc.) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Healthcare Organ Donation & Transplant Software market, Deployment Mode outlook key takeaways (USD Million)
  • Fig. 18 Healthcare Organ Donation & Transplant Software market: Deployment Mode movement analysis (USD Million)
  • Fig. 19 Cloud-based market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 On-premise market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Organ Donation & Transplant Software market, Application outlook key takeaways (USD Million)
  • Fig. 22 U.S. Organ Donation & Transplant Software market: Application Mode movement analysis (USD Million)
  • Fig. 23 Organ Donation Workflow Automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Waitlist & Recipient Management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Transplant Coordination & Scheduling market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Regulatory Reporting & Compliance market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Outcome & Data Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Organ Donation & Transplant Software market, End Use outlook key takeaways (USD Million)
  • Fig. 29 U.S. Organ Donation & Transplant Software market: End Use Mode movement analysis (USD Million)
  • Fig. 30 Hospitals & Transplant Centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Organ Procurement Organizations (OPOs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 National/Regional Health Agencies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Research & Academic Institutes market estimates and forecasts, 2021 - 2033 (USD Million)